Skip to main content
TipRanks
Go Ultimate75% OFF

Pacira Pharmaceuticals (82P) Q3 2024 Earnings Report

0 Followers

DE:82P Q3 2024 EPS Results

Actual EPS
EUR 0.72
Consensus EPS
EUR 0.64
Beat/Miss
Beat by +EUR 0.08
One Year Ago EPS
EUR 0.65

DE:82P Q3 2024 Revenue Results

Actual Revenue
EUR 153.33M
Expected Revenue
EUR 154.21M
Beat/Miss
Missed by -EUR 885.90K
YoY Revenue Growth
+2.83%

Earnings Announcement Details

Quarter
Q3 2024
Date
11/06/2024
Time
After Close
Conference Call
Wednesday, November 6, 2024
DE:82P Upcoming Earnings

Pacira Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q3 2024 Earnings Call Audio

DE:82P Q3 2024 Earnings Call
0:00 / 0:00

Q3 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:82P Earnings History

DE:82P earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)―-0.52――
Oct 29, 20262026 (Q3)0.690.630.64-0.29% (-0.00)
Aug 04, 20262026 (Q2)0.590.660.67-1.35% (-0.01)
Apr 30, 20262026 (Q1)0.500.550.56-3.23% (-0.02)
Feb 26, 20262025 (Q4)0.820.520.83-37.36% (-0.31)
Nov 06, 20252025 (Q3)0.620.640.72-11.39% (-0.08)
Aug 05, 20252025 (Q2)0.650.670.81-16.85% (-0.14)
May 08, 20252025 (Q1)0.540.560.560.00% (+0.00)
Feb 27, 20252024 (Q4)0.760.830.812.25% (+0.02)
Nov 06, 20242024 (Q3)0.640.720.659.72% (+0.06)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed